Mumbai: Senior Maharashtra cadre IAS officer Tukaram Mundhe has firmly dismissed speculation about his transfer from the Food and Drug Administration (FDA), clarifying that he continues to serve as the department’s Commissioner and that its enforcement drive against unsafe food and substandard medicines will continue across the state.
The 2005-batch IAS officer issued the clarification on Monday night, October 12, through a post on social media platform X, amid widespread speculation that he had been transferred following his appointment as secretary of a high-level committee constituted by the Maharashtra government to examine alleged irregularities in the Maharashtra Public Service Commission (MPSC).
Rejecting the rumours, Mundhe stated that he had not been transferred from the FDA and reaffirmed his commitment to tackling food adulteration, unsafe products and spurious medicines.
His statement comes at a time when the Maharashtra FDA’s intensified inspections and enforcement measures have attracted considerable public attention, drawing appreciation from consumers while also facing resistance from sections of the food and restaurant industry.
What Did IAS Tukaram Mundhe Say About His Transfer?
In his post on X, Mundhe categorically denied the reports suggesting that he had been moved out of the Food and Drug Administration.
He wrote: “No, I have not been transferred from FDA. नाही, माझी FDA मधून बदली झालेली नाही. I continue to serve as Commissioner, FDA Maharashtra. Our fight against unsafe, substandard, adulterated food and spurious, substandard drugs goes on.”
Through the statement, Mundhe made it clear that his appointment to the MPSC inquiry committee did not mean that he had relinquished his existing responsibilities as FDA Commissioner.
His clarification also reiterated the department’s continued focus on enforcing food and drug safety regulations, particularly against unsafe, adulterated and substandard products.
The statement assumes significance because Mundhe has faced frequent transfers during his administrative career, making speculation about changes in his postings a recurring subject of public discussion.
Read also: One ‘+’ Sparks Big Action: IAS Tukaram Mundhe Cracks Down on Cadila’s Aciloc Mix-Up
Transfer Speculation Followed Appointment to MPSC Inquiry Committee
The rumours surrounding Mundhe’s transfer emerged after the Maharashtra government appointed him secretary of a five-member inquiry committee formed to investigate allegations of examination irregularities, including suspected question paper leaks, in the Maharashtra Public Service Commission.
The committee was constituted following a prolonged agitation by MPSC aspirants in Pune, who had been demanding reforms in the state’s recruitment system and action over alleged irregularities in examinations.
The aspirants had staged protests for ten consecutive days at S M Joshi Bridge in Pune, pressing the government to address concerns about transparency, accountability and the functioning of the recruitment body.
The state government subsequently accepted several of their demands and announced the formation of an inquiry committee with Mundhe in a key administrative role.
However, the announcement led to speculation that Mundhe might have been transferred from the FDA to take up his responsibilities on the committee.
His clarification on Monday night put those rumours to rest, confirming that he continues to hold the FDA Commissioner’s post.
Former Judge Dilip Bhosale to Head MPSC Inquiry Panel
The five-member committee has been constituted to examine alleged irregularities in the Maharashtra Public Service Commission and recommend measures relating to its functioning.
Maharashtra minister Shivendraraje Bhosale announced the formation of the committee on Sunday after meeting the protesting MPSC aspirants at S M Joshi Bridge in Pune.
The committee comprises:
- Former Bombay High Court judge Dilip Bhosale – Chairman
- IAS officer Tukaram Mundhe – Secretary
- IPS officer Lakshmi Gautam – Member
- Former IAS officer Ganesh Patil – Member
- Retired judge P D Naik – Member
The committee will examine allegations concerning MPSC examinations and the functioning of the state recruitment body.
Chief Minister Devendra Fadnavis had also indicated that the inquiry would examine the tenure of current and former chairpersons and members of the commission.
The panel’s formation is being viewed as an important administrative response to the demands raised by aspirants seeking greater transparency in Maharashtra’s competitive examination and recruitment system.
MPSC Aspirants End 10-Day Agitation After Government’s Assurance
The appointment of Tukaram Mundhe to the inquiry committee was among the significant developments that preceded the withdrawal of the MPSC aspirants’ ten-day agitation.
The protesting candidates had demanded an independent investigation into alleged paper leaks and recruitment irregularities, along with reforms in the commission’s functioning.
A state government delegation led by minister Shivendraraje Bhosale met the protesters and informed them that several of their demands had been accepted.
One of the principal demands concerned MPSC Chairman Vivek Bhimanwar, whose removal had been sought by the aspirants.
Following discussions, Bhimanwar announced that he would proceed on leave until the inquiry was completed, citing ethical considerations.
The protesters subsequently called off their agitation, with the formation of the inquiry committee and Mundhe’s inclusion among the developments that helped resolve the immediate standoff.
The government also accepted demands concerning the withdrawal of cases against protesters, recruitment to 70,000 posts over three years and background verification for appointments to senior MPSC positions.
IAS Tukaram Mundhe’s FDA Crackdown Draws Public Attention
While his appointment to the MPSC committee has generated considerable discussion, Mundhe’s tenure as Maharashtra FDA Commissioner has already placed him in the public spotlight.
Under his leadership, the department has intensified enforcement measures against alleged violations of food safety and drug quality regulations.
The FDA has conducted inspections, raids and regulatory actions involving restaurants, eateries and other food businesses suspected of violating prescribed safety and compliance requirements.
The department’s enforcement drive has focused on identifying unsafe, adulterated and substandard food products, along with addressing concerns related to spurious and poor-quality medicines.
Actions have also been taken against establishments over licensing issues and non-compliance with applicable food safety regulations.
These measures have brought renewed attention to the responsibility of food businesses to maintain hygiene, product quality and regulatory compliance.
Mundhe’s latest statement indicates that the enforcement drive will continue despite his additional assignment on the MPSC inquiry committee.
Consumers Welcome Enforcement, Restaurant Industry Raises Objections
The FDA’s intensified action under Mundhe has generated differing responses among consumers and business operators.
Many consumers have welcomed the department’s emphasis on food safety, quality standards and accountability, particularly amid concerns over adulteration and unsafe products.
The enforcement measures have also drawn attention to the importance of regular inspections and strict compliance with food safety requirements.
However, sections of the restaurant and food business industry have expressed opposition to certain actions taken against their establishments.
Some operators have questioned aspects of the enforcement measures, while certain regulatory actions have also been challenged before courts.
The legal challenges have brought parts of the FDA’s enforcement approach under judicial scrutiny.
The contrasting reactions reflect the tensions that can arise between strict regulatory enforcement and concerns raised by businesses over the manner in which compliance measures are implemented.
Despite the opposition, Mundhe has reiterated that the department’s action against unsafe food and substandard medicines will continue.
Who Is IAS Tukaram Mundhe?
Tukaram Mundhe is a 2005-batch Indian Administrative Service officer of the Maharashtra cadre, known for his strict administrative approach and emphasis on enforcing government rules and regulations.
During his career, he has held several administrative assignments and developed a public reputation for taking firm decisions, often attracting attention for his uncompromising style of functioning.
His administrative career has also been marked by frequent transfers, making his postings a subject of considerable public interest.
As Commissioner of the Maharashtra Food and Drug Administration, Mundhe has been associated with an intensified regulatory drive aimed at improving food safety standards and strengthening action against violations.
His work in the department has attracted international attention as well, with the American newspaper The New York Times highlighting the impact of his aggressive food safety enforcement drive in Maharashtra.
His appointment as secretary of the MPSC inquiry committee has further increased attention on his administrative role, particularly among aspirants demanding an impartial examination of alleged recruitment irregularities.
FDA Enforcement to Continue Alongside MPSC Inquiry Responsibilities
Mundhe’s clarification establishes that he remains Maharashtra FDA Commissioner even after being appointed secretary of the MPSC inquiry committee.
The two responsibilities involve different areas of public administration.
While the FDA oversees compliance with food and drug safety regulations, the MPSC inquiry committee has been constituted to examine alleged irregularities and concerns surrounding the state’s public recruitment system.
The committee’s work will involve examining the allegations and reviewing issues relating to the functioning of the recruitment body, while Mundhe’s existing FDA responsibilities remain unchanged.
His public statement has therefore addressed the uncertainty surrounding his position and reaffirmed the continuation of the department’s regulatory action.
With the MPSC inquiry process now set to proceed, attention will remain on the committee’s findings and the government’s response to its recommendations.
Meanwhile, Mundhe’s message is clear: he has not been transferred from the Maharashtra FDA, and the campaign against unsafe and adulterated food and spurious or substandard medicines will continue.
